Skip to main content
SpringerLink
Log in

Lymphedema Prospective Surveillance and Risk Reduction

  • Chapter
  • First Online:
Multimodal Management of Upper and Lower Extremity Lymphedema

Abstract

There are modifiable and non-modifiable risk factors associated with the onset of cancer treatment-related lymphedema. Identifying individual risk factors and prospectively monitoring those who are at risk for developing lymphedema is an evidence-based approach to enable early identification and treatment of lymphedema and may prevent the progression of the condition to a more chronic condition. The purpose of this chapter is to review the evidence for risk-reduction activities and to outline how a prospective surveillance model could enable improved detection and management of lymphedema in a clinical setting.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Grada AA, Phillips TJ. Lymphedema: pathophysiology and clinical manifestations. J Am Acad Dermatol. 2017;77(6):1009–20.

    Article  PubMed  Google Scholar 

  2. Ridner SH. Pathophysiology of lymphedema. Semin Oncol Nurs. 2013;29(1):4–11.

    Article  PubMed  Google Scholar 

  3. Pfarr KM, Debrah AY, Specht S, Hoerauf A. Filariasis and lymphoedema. Parasite Immunol. 2009;31(11):664–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, et al. Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin. 2015;65(1):55–81.

    Article  PubMed  Google Scholar 

  5. Anand A, Balasubramanian D, Subramanian N, Murthy S, Limbachiya S, Iyer S, et al. Secondary lymphedema after head and neck cancer therapy: a review. Lymphology. 2018;51(3):109–18.

    CAS  PubMed  Google Scholar 

  6. Mendivil AA, Rettenmaier MA, Abaid LN, Brown JV 3rd, Micha JP, Lopez KL, et al. Lower-extremity lymphedema following management for endometrial and cervical cancer. Surg Oncol. 2016;25(3):200–4.

    Article  PubMed  Google Scholar 

  7. Ki EY, Park JS, Lee KH, Hur SY. Incidence and risk factors of lower extremity lymphedema after gynecologic surgery in ovarian cancer. Int J Gynecol Cancer. 2016;26(7):1327–32.

    Article  PubMed  Google Scholar 

  8. Friedman JF, Sunkara B, Jehnsen JS, Durham A, Johnson T, Cohen MS. Risk factors associated with lymphedema after lymph node dissection in melanoma patients. Am J Surg. 2015;210(6):1178–84. discussion 84

    Article  PubMed  Google Scholar 

  9. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.

    Article  PubMed  Google Scholar 

  10. Rockson SG. The genetic predisposition to breast cancer-associated lymphedema. Mary Ann Liebert, Inc; 2019.

    Book  Google Scholar 

  11. Byun HK, Chang JS, Im SH, Kirova YM, Arsene-Henry A, Choi SH, et al. Risk of lymphedema following contemporary treatment for breast cancer: an analysis of 7617 consecutive patients from a multidisciplinary perspective. Ann Surg. 2019;274(1):170–8.

    Article  Google Scholar 

  12. McLaughlin SA, Brunelle CL, Taghian A. Breast cancer-related lymphedema: risk factors, screening, management, and the impact of locoregional treatment. J Clin Oncol. 2020;38(20):2341–50.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Rupp J, Hadamitzky C, Henkenberens C, Christiansen H, Steinmann D, Bruns F. Frequency and risk factors for arm lymphedema after multimodal breast-conserving treatment of nodal positive breast cancer – a long-term observation. Radiat Oncol. 2019;14(1):39.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Warren LE, Miller CL, Horick N, Skolny MN, Jammallo LS, Sadek BT, et al. The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys. 2014;88(3):565–71.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Carlson JW, Kauderer J, Hutson A, Carter J, Armer J, Lockwood S, et al. GOG 244-The lymphedema and gynecologic cancer (LEG) study: incidence and risk factors in newly diagnosed patients. Gynecol Oncol. 2020;156(2):467–74.

    Article  PubMed  Google Scholar 

  16. Kuroda K, Yamamoto Y, Yanagisawa M, Kawata A, Akiba N, Suzuki K, et al. Risk factors and a prediction model for lower limb lymphedema following lymphadenectomy in gynecologic cancer: a hospital-based retrospective cohort study. BMC Womens Health. 2017;17(1):50.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Hayes SC, Janda M, Ward LC, Reul-Hirche H, Steele ML, Carter J, et al. Lymphedema following gynecological cancer: results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors. Gynecol Oncol. 2017;146(3):623–9.

    Article  PubMed  Google Scholar 

  18. Biglia N, Zanfagnin V, Daniele A, Robba E, Bounous VE. Lower body lymphedema in patients with gynecologic cancer. Anticancer Res. 2017;37(8):4005–15.

    PubMed  Google Scholar 

  19. Todo Y, Yamazaki H, Takeshita S, Ohba Y, Sudo S, Minobe S, et al. Close relationship between removal of circumflex iliac nodes to distal external iliac nodes and postoperative lower-extremity lymphedema in uterine corpus malignant tumors. Gynecol Oncol. 2015;139(1):160–4.

    Article  PubMed  Google Scholar 

  20. Kunitake T, Kakuma T, Ushijima K. Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment. Int J Clin Oncol. 2020;25(5):963–71.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Tribius S, Pazdyka H, Tennstedt P, Busch C-J, Hanken H, Krüll A, et al. Prognostic factors for lymphedema in patients with locally advanced head and neck cancer after combined radio (chemo) therapy-results of a longitudinal study. Oral Oncol. 2020;109:104856.

    Article  CAS  PubMed  Google Scholar 

  22. Deng J, Wulff-Burchfield EM, Murphy BA. Late soft tissue complications of head and neck cancer therapy: lymphedema and fibrosis. J Natl Cancer Inst Monogr. 2019;2019(53):lgz005.

    Article  CAS  PubMed  Google Scholar 

  23. Ridner SH, Dietrich MS, Sonis ST, Murphy B. Biomarkers associated with lymphedema and fibrosis in patients with cancer of the head and neck. Lymphat Res Biol. 2018;16(6):516–24.

    Article  CAS  PubMed Central  Google Scholar 

  24. Deng J, Ridner SH, Dietrich MS, Wells N, Wallston KA, Sinard RJ, et al. Factors associated with external and internal lymphedema in patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2012;84(3):e319–28.

    Article  PubMed  Google Scholar 

  25. Wu X, Liu Y, Zhu D, Wang F, Ji J, Yan H. Early prevention of complex decongestive therapy and rehabilitation exercise for prevention of lower extremity lymphedema after operation of gynecologic cancer. Asian J Surg. 2020;44(1):111–5.

    Article  PubMed  Google Scholar 

  26. Asdourian MS, Skolny MN, Brunelle C, Seward CE, Salama L, Taghian AG. Precautions for breast cancer-related lymphoedema: risk from air travel, ipsilateral arm blood pressure measurements, skin puncture, extreme temperatures, and cellulitis. Lancet Oncol. 2016;17(9):e392–405.

    Article  PubMed  Google Scholar 

  27. Ferguson CM, Swaroop MN, Horick N, Skolny MN, Miller CL, Jammallo LS, et al. Impact of ipsilateral blood draws, injections, blood pressure measurements, and air travel on the risk of lymphedema for patients treated for breast cancer. J Clin Oncol. 2016;34(7):691–8.

    Article  PubMed  Google Scholar 

  28. Armer JM, Hulett JM, Bernas M, Ostby P, Stewart BR, Cormier JN. Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Cancer Rep. 2013;5(2):134–44.

    Article  PubMed  PubMed Central  Google Scholar 

  29. McLaughlin SA, Stout NL, Schaverien MV. Avoiding the swell: advances in lymphedema prevention, detection, and management. Am Soc Clin Oncol Educ Book. 2020;40:e17–26.

    Article  Google Scholar 

  30. Bland KL, Kosir MA. Improving the quality of life in breast cancer survivors at risk for lymphedema. Surgery. 2019;166(4):686–90.

    Article  PubMed  Google Scholar 

  31. Gillespie TC, Sayegh HE, Brunelle CL, Daniell KM, Taghian AG. Breast cancer-related lymphedema: risk factors, precautionary measures, and treatments. Gland Surg. 2018;7(4):379–403.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Hnin YK, Ong LX, Tsai CC, Ong SS, Yee SG, Choo BA, et al. Does initial routine use of a compression garment reduce the risk of lower limb lymphedema after gynecological cancer treatment? A randomized pilot study in an Asian institution and review of the literature. Lymphology. 2018;51(4):174–83.

    CAS  PubMed  Google Scholar 

  33. Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P. Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer. 2008;112(12):2809–19.

    Article  PubMed  Google Scholar 

  34. Li F, Lu Q, Jin S, Zhao Q, Qin X, Jin S, et al. A scoring system for predicting the risk of breast cancer-related lymphedema. Int J Nurs Sci. 2020;7(1):21–8.

    PubMed  Google Scholar 

  35. Stout NL, Binkley JM, Schmitz KH, Andrews K, Hayes SC, Campbell KL, et al. A prospective surveillance model for rehabilitation for women with breast cancer. Cancer. 2012;118(S8):2191–200.

    Article  PubMed  Google Scholar 

  36. Chance-Hetzler J, Armer J, Van Loo M, Anderson B, Harris R, Ewing R, et al. Prospective lymphedema surveillance in a clinic setting. J Pers Med. 2015;5(3):311–25.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Lai L, Binkley J, Jones V, Kirkpatrick S, Furbish C, Stratford P, et al. Implementing the prospective surveillance model (PSM) of rehabilitation for breast cancer patients with 1-year postoperative follow-up, a prospective, observational study. Ann Surg Oncol. 2016;23(10):3379–84.

    Article  PubMed  Google Scholar 

  38. Rafn BS, Hung S, Hoens AM, McNeely ML, Singh CA, Kwan W, et al. Prospective surveillance and targeted physiotherapy for arm morbidity after breast cancer surgery: a pilot randomized controlled trial. Clin Rehabil. 2018;32(6):811–26.

    Article  PubMed  Google Scholar 

  39. Levenhagen K, Davies C, Perdomo M, Ryans K, Gilchrist L. Diagnosis of upper quadrant lymphedema secondary to cancer: clinical practice guideline from the Oncology Section of the American Physical Therapy Association. Phys Ther. 2017;97(7):729–45.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Ancukiewicz M, Russell TA, Otoole J, Specht M, Singer M, Kelada A, et al. Standardized method for quantification of developing lymphedema in patients treated for breast cancer. Int J Radiat Oncol Biol Phys. 2011;79(5):1436–43.

    Article  PubMed  Google Scholar 

  41. Purcell A, Nixon J, Fleming J, McCann A, Porceddu S. Measuring head and neck lymphedema: the “ALOHA” trial. Head Neck. 2016;38(1):79–84.

    Article  PubMed  Google Scholar 

  42. Yost KJ, Cheville AL, Weaver AL, Al Hilli M, Dowdy SC. Development and validation of a self-report lower-extremity lymphedema screening questionnaire in women. Phys Ther. 2013;93(5):694–703.

    Article  PubMed  Google Scholar 

  43. Doersam JK, Dietrich MS, Adair MA, Rhoten B, Deng J, Ridner SH. A comparison of symptoms among patients with head and neck or truncal lymphedema and normal controls. Lymphat Res Biol. 2019;17(6):661–70.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Mayrovitz HN, Mikulka A, Woody D. Minimum detectable changes associated with tissue dielectric constant measurements as applicable to assessing lymphedema status. Lymphat Res Biol. 2019;17(3):322–8.

    Article  PubMed  Google Scholar 

  45. Shah C, Vicini FA, Arthur D. Bioimpedance spectroscopy for breast cancer related lymphedema assessment: clinical practice guidelines. Breast J. 2016;22(6):645–50.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. West Virginia University Cancer Institute, School of Medicine, Department of Hematology Oncology, Morgantown, WV, USA

    Nicole L. Stout

  2. University of Missouri, Sinclair School of Nursing, Ellis Fischel Cancer Center, Columbia, MO, USA

    Jane M. Armer

Authors
  1. Nicole L. Stout
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jane M. Armer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Nicole L. Stout or Jane M. Armer .

Editor information

Editors and Affiliations

  1. Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Mark V. Schaverien

  2. Division of Plastic and Reconstructive Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Joseph H. Dayan

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Stout, N.L., Armer, J.M. (2022). Lymphedema Prospective Surveillance and Risk Reduction. In: Schaverien, M.V., Dayan, J.H. (eds) Multimodal Management of Upper and Lower Extremity Lymphedema. Springer, Cham. https://doi.org/10.1007/978-3-030-93039-4_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-93039-4_4

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-93038-7

  • Online ISBN: 978-3-030-93039-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation